Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People on Optimized ART With Undetectable Plasma HIV RNA
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2019
Price : $35 *
At a glance
- Drugs ALT 803 (Primary) ; ALT 803 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 30 Oct 2019 Status changed from recruiting to active, no longer recruiting.
- 29 Mar 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 Mar 2019 Planned primary completion date changed from 1 Jul 2018 to 30 Sep 2019.